Longboard Pharmaceuticals Inc (LBPH) Stock Analyst Ratings
USA - NASDAQ:LBPH - US54300N1037 - Common Stock
59.98 USD
+0.02 (+0.03%)
60.01 USD
+0.03 (+0.05%)
ChartMill assigns a Buy % Consensus number of 75% to LBPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 65.96. This target is 9.97% above the current price.
LBPH was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about LBPH.
In the previous month the buy percentage consensus was at a similar level.
LBPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-15 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-10-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-10-14 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-10-14 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-09-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-17 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-10 | Truist Securities | Initiate | Buy |
| 2024-08-26 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-08-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-02 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-11 | Baird | Maintains | Outperform -> Outperform |
| 2024-07-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-07-02 | Citigroup | Maintains | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-20 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-06-11 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-03 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-05-01 | Baird | Initiate | Outperform |
| 2024-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
Longboard Pharmaceuticals Inc / LBPH FAQ
Can you provide the average price target for Longboard Pharmaceuticals Inc stock?
13 analysts have analysed LBPH and the average price target is 65.96 USD. This implies a price increase of 9.97% is expected in the next year compared to the current price of 59.98.
What is the consensus rating for Longboard Pharmaceuticals Inc (LBPH) stock?
The consensus rating for Longboard Pharmaceuticals Inc (LBPH) is 75.3846 / 100 . This indicates that analysts generally have a positive outlook on the stock.